Quest Diagnostics Inc. Revenue 2007–2025
Quest Diagnostics Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Quest Diagnostics Inc. revenue for the quarter ending March 31, 2026 was 2.9 B, a 9.16% increase year-over-year.
- Quest Diagnostics Inc. revenue for the twelve months ending March 31, 2026 was 11.1 B, a 16.53% increase year-over-year.
- Quest Diagnostics Inc. annual revenue for 2025 was 11.0 B, a 11.78% increase from 2024.
- Quest Diagnostics Inc. annual revenue for 2024 was 9.9 B, a 6.70% increase from 2023.
- Quest Diagnostics Inc. annual revenue for 2023 was 9.3 B, a 6.38% decrease from 2022.
- Quest Diagnostics Inc. annual revenue for 2022 was 9.9 B.
Quest Diagnostics Inc. (DGX) — Frequently Asked Questions
Quest Diagnostics Inc. (DGX) is a publicly traded US company. It has a market capitalization of $22.95B. In fiscal 2025 it reported revenue of $11.04B and net income of $992M. Explore DGX's stock price, financial statements, earnings history, margins and key ratios below.
What is Quest Diagnostics Inc.'s market cap?
Quest Diagnostics Inc. (DGX) has a market capitalization of $22.95B.
What is the DGX stock price?
DGX trades at $203.14 (-0.31% on the day).
How much revenue does Quest Diagnostics Inc. make?
Quest Diagnostics Inc. reported revenue of $11.04B in fiscal 2025.
Is DGX profitable?
In fiscal 2025, Quest Diagnostics Inc. reported net income of $992M.